368 related articles for article (PubMed ID: 26694875)
1. Therapeutic l-asparaginase: upstream, downstream and beyond.
Lopes AM; Oliveira-Nascimento L; Ribeiro A; Tairum CA; Breyer CA; Oliveira MA; Monteiro G; Souza-Motta CM; Magalhães PO; Avendaño JG; Cavaco-Paulo AM; Mazzola PG; Rangel-Yagui CO; Sette LD; Converti A; Pessoa A
Crit Rev Biotechnol; 2017 Feb; 37(1):82-99. PubMed ID: 26694875
[TBL] [Abstract][Full Text] [Related]
2. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
3. Enhanced catalysis of L-asparaginase from Bacillus licheniformis by a rational redesign.
Sudhir AP; Agarwaal VV; Dave BR; Patel DH; Subramanian RB
Enzyme Microb Technol; 2016 May; 86():1-6. PubMed ID: 26992786
[TBL] [Abstract][Full Text] [Related]
4. Expanding targets for a metabolic therapy of cancer: L-asparaginase.
Covini D; Tardito S; Bussolati O; Chiarelli LR; Pasquetto MV; Digilio R; Valentini G; Scotti C
Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):4-13. PubMed ID: 21854356
[TBL] [Abstract][Full Text] [Related]
5. Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.
Miranda J; Lefin N; Beltran JF; Belén LH; Tsipa A; Farias JG; Zamorano M
BioDrugs; 2023 Nov; 37(6):793-811. PubMed ID: 37698749
[TBL] [Abstract][Full Text] [Related]
6. Isolation, Purification, Characterisation and Application of L-ASNase: A Review.
Paul T; Mondal A; Bandyopadhyay TK
Recent Pat Biotechnol; 2019; 13(1):33-44. PubMed ID: 30318009
[TBL] [Abstract][Full Text] [Related]
7. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.
Avramis VI; Tiwari PN
Int J Nanomedicine; 2006; 1(3):241-54. PubMed ID: 17717965
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships and clinical applications of L-asparaginases.
Labrou NE; Papageorgiou AC; Avramis VI
Curr Med Chem; 2010; 17(20):2183-95. PubMed ID: 20423302
[TBL] [Abstract][Full Text] [Related]
9. Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer.
Costa-Silva TA; Costa IM; Biasoto HP; Lima GM; Silva C; Pessoa A; Monteiro G
Blood Rev; 2020 Sep; 43():100651. PubMed ID: 32014342
[TBL] [Abstract][Full Text] [Related]
10. Monolith and coating enzymatic microreactors of L-asparaginase: kinetics study by MCE-LIF for potential application in acute lymphoblastic leukemia (ALL) treatment.
Qiao J; Qi L; Mu X; Chen Y
Analyst; 2011 May; 136(10):2077-83. PubMed ID: 21461410
[TBL] [Abstract][Full Text] [Related]
11. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
Yamada T; Ishimaru M; Shoji T; Tomiyasu H; Tochinai R; Taguchi K; Komatsu T
ACS Appl Bio Mater; 2023 Dec; 6(12):5789-5797. PubMed ID: 38047730
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review on L-Asparaginase and Its Applications.
Batool T; Makky EA; Jalal M; Yusoff MM
Appl Biochem Biotechnol; 2016 Mar; 178(5):900-23. PubMed ID: 26547852
[TBL] [Abstract][Full Text] [Related]
13. Microbial L-asparaginase as a promising enzyme for treatment of various cancers.
Darvishi F; Jahanafrooz Z; Mokhtarzadeh A
Appl Microbiol Biotechnol; 2022 Sep; 106(17):5335-5347. PubMed ID: 35871694
[TBL] [Abstract][Full Text] [Related]
14. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
[TBL] [Abstract][Full Text] [Related]
15. L-asparaginase production review: bioprocess design and biochemical characteristics.
Castro D; Marques ASC; Almeida MR; de Paiva GB; Bento HBS; Pedrolli DB; Freire MG; Tavares APM; Santos-Ebinuma VC
Appl Microbiol Biotechnol; 2021 Jun; 105(11):4515-4534. PubMed ID: 34059941
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor.
Asselin BL; Lorenson MY; Whitin JC; Coppola DJ; Kende AS; Blakley RL; Cohen HJ
Cancer Res; 1991 Dec; 51(24):6568-73. PubMed ID: 1742729
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Microbial L-Asparaginases: from Production to Practical Applications.
Sharma D; Singh K; Singh K; Mishra A
Curr Protein Pept Sci; 2019; 20(5):452-464. PubMed ID: 30426897
[TBL] [Abstract][Full Text] [Related]
18. A critical analysis of L-asparaginase activity quantification methods-colorimetric methods versus high-performance liquid chromatography.
Magri A; Soler MF; Lopes AM; Cilli EM; Barber PS; Pessoa A; Pereira JFB
Anal Bioanal Chem; 2018 Nov; 410(27):6985-6990. PubMed ID: 30155702
[TBL] [Abstract][Full Text] [Related]
19. Tailoring structure-function properties of L-asparaginase: engineering resistance to trypsin cleavage.
Kotzia GA; Lappa K; Labrou NE
Biochem J; 2007 Jun; 404(2):337-43. PubMed ID: 17313368
[TBL] [Abstract][Full Text] [Related]
20. Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.
Shishparenok AN; Gladilina YA; Zhdanov DD
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]